U.S. Bacteriological Testing Market Insight
U.S. Bacteriological Testing market size is growing at a 7.63% CAGR, driven by the rising infectious diseases, stringent food safety regulations, pharmaceutical quality control needs, water safety concerns, and technological advancements drive bacteriological testing demand.
U.S. Bacteriological Testing Market Insights Forecasts to 2035
- The U.S. Bacteriological Testing Market Size Was Estimated at USD 2.93 Billion in 2025.
- The Market Size is Expected to Grow at a CAGR of around 7.63% from 2025 to 2035.
- The U.S. Bacteriological Testing Market Size is Expected to Reach USD 6.11 Billion by 2035.
Notable Insights for U.S. Bacteriological Testing Market
- By product, reagents and consumables dominated the market with around 45% share in 2024, driven by continuous demand for routine laboratory and diagnostic testing.
- According to industry estimates, the U.S. bacteriological testing market reached USD 4.87 billion in 2024, reflecting strong expansion across healthcare, food safety, and environmental applications.
- Government health data highlights rising infectious disease cases and antimicrobial resistance, significantly increasing demand for microbiological and bacteriological testing solutions across clinical settings.
- Regional data indicates the Midwest and South account for over 40% market share, supported by large-scale food production, agriculture, and strict regulatory compliance requirements.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the U.S. Bacteriological Testing market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in U.S. Bacteriological Testing Market
- Thermo Fisher Scientific
- Danaher Corporation
- Becton, Dickinson and Company
- Abbott Laboratories
- Bio-Rad Laboratories
- Neogen Corporation
- 3M Company
- Charles River Laboratories
- Pace Analytical Services
Recent Developments:
• In March 2025, Nelson Labs launched rapid sterility testing services using advanced microbiological methods across multiple U.S. laboratories, enhancing faster detection for pharmaceutical and medical device testing.
• In January 2026, Labcorp divested its U.S.-based microbiological and analytical testing assets to NAMSA, strengthening specialization and efficiency in medical device and laboratory testing services.
• In 2025, increasing adoption of rapid microbiology testing technologies accelerated across U.S. healthcare and food industries, driven by demand for faster and more accurate pathogen detection.
• In 2024–2025, rising investments in pharmaceutical R&D and biologics production significantly expanded demand for bacteriological testing to ensure regulatory compliance and product safety.
• In 2025, advancements in microbial identification technologies, including PCR and automated systems, improved testing accuracy and efficiency across clinical and industrial applications.
Market Segmentation:
U.S. Bacteriological Testing Market, By Technology
• Culture-Based Methods
• Molecular Diagnostics (PCR, qPCR)
• Immunoassays
• Rapid Microbiological Methods (RMM)
• Mass Spectrometry (e.g., MALDI-TOF)
U.S. Bacteriological Testing Market, By Component
• Instruments
• Reagents & Consumables
• Services
U.S. Bacteriological Testing Market, By Application
• Clinical Diagnostics
• Food & Beverage Testing
• Pharmaceutical & Biotechnology Testing
• Water & Environmental Testing
• Agriculture Testing
Expert Views:
Industry experts highlight that the U.S. bacteriological testing market is undergoing steady transformation driven by rising infectious disease prevalence, stringent regulatory standards, and growing demand for food and water safety. Specialists emphasize that the shift toward rapid microbiological methods and molecular diagnostics is significantly improving testing speed, accuracy, and operational efficiency across laboratories. Experts also note that increasing pharmaceutical and biotechnology production is accelerating the need for contamination control and quality assurance testing. .